Skip to main content
High RiskFDAfda-F-1387-2023UNDECLARED ALLERGEN

Sweet Alchemy Lemon Custard ice cream, distributed in cups. Label declares company name, flavor name, but does not declare ingredients an...

Category
Units Affected
8
Recall Date
June 30, 2023
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1387-2023.

Ice cream grab n go Cup containers' labels do not declare any ingredients including allergens Egg and Milk.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1387-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Sweet Alchemy Ice Creamery, Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1387-2023.

Sweet Alchemy Ice Creamery, Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Sweet Alchemy Ice Creamery, Inc Recall FAQ

Sweet Alchemy Ice Creamery, Inc is the subject of a dairy safety report: Sweet Alchemy Lemon Custard ice cream, distributed in cups. Label declares company name, flavor name, but does not declare ingredients an.... The notice was published on June 30, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 8 units are potentially affected.